Archives

by in
Entry Author Date Location
What Biotech Pros Will Be Chirping About at JP Morgan This Week 01/13/14 National
Tal Medical Gets NIMH Backing for Fast-Acting Depression Therapy 01/10/14 Boston
Zymeworks Nabs $15M, Adds Lilly Partnership, in Antibody Drug Quest 01/09/14 Seattle
Tillman Gerngross, the Scientist Turned Scientific Businessman 01/09/14 Boston
Flexion Files for IPO, Seeks $86M to Develop Osteoarthritis Drugs 01/08/14 Boston
Radius Health Churns Through 3 CEOs, as Osteoporosis Drug Delayed 12/20/13 Boston
Sam Sia’s NY Biotech Incubator Already Bustling With 16 Startups 12/13/13 New York
East Coast Biotech Roundup: Juno, Editas, Celgene, & More 12/06/13 Boston
NYCEDC Amassing $100M Biotech Fund; Boehringer Jumps Into Kendall Square 12/04/13 New York
East Coast Biotech Roundup: Moderna, Aileron, Seres, & More 11/22/13 Boston
Big Pharma Quartet Puts $30M Behind Aileron’s P53 Peptide Drug 11/18/13 Boston
How Alkermes Survived a Brush With Death 11/11/13 National
Zalicus Awaits Day of Reckoning, Braces For Key Pain Drug Results 11/11/13 Boston
The Pharma Bureaucracy Index: Who’s Nimble, and Who’s Sloooowww? 09/30/13 National
Aileron Goes After Cancer’s Hard Target, P53, With Peptide Drug 09/03/13 Boston
Technology to Assess Neurons Gives New Life to San Diego’s Afraxis 08/19/13 San Diego
Ensemble Reels in Novartis to Develop Oral, Mid-Sized Inflammation Drugs 08/06/13 Boston
Adimab Turns Cash Flow Positive With GSK, Biogen Tech Transfer Deals 07/26/13 Boston
Agios Prices Upsized IPO Above Range, Preps For Nasdaq Debut 07/24/13 Boston
Alkermes Adds Cancer, MS Drugs To Growing Portfolio 07/17/13 Boston
Flexion’s Long-Lasting Steroid Injection Hits Mark in Phase 2 Trial 06/26/13 Boston
Agios Files For IPO With Plans to Raise $86M 06/11/13 Boston
CytomX Snags $25M From Pfizer to Make Souped-Up Antibodies 06/06/13 San Francisco
XBiotech Takes Aim at Inflammation That Weakens Cancer Patients 05/17/13 Texas
Radius Health CEO: Skin Patch Data is the Value Driver 05/13/13 Boston
Biotech Execs Aren’t Ready to Prove Drugs Have Value, E&Y Says 04/23/13 National
Michigan Life Sciences Roundup: Swift Biosciences, Aastrom 03/11/13 Detroit
UW Spinoff Resolve Therapeutics Lures In Takeda, Lines Up Return 02/27/13 Seattle
Third Rock’s Bet on Lotus Tissue Repair Generates Big Return 02/27/13 Boston
Adimab Grows Up, Looks to Pay Off the VCs In Unusual Way 02/22/13 Boston
Page 2 of 10 « previous page · next page »